CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF...Master Development and Manufacturing Services Agreement • January 24th, 2025 • Aurion Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 24th, 2025 Company IndustryTHIS MASTER DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT is made as of April 1, 2021 (the “Effective Date”) by and among CORNEAGEN INC. (“CorneaGen US”), a Delaware corporation, having an address at [Omitted] and its wholly owned subsidiary, CorneaGen Japan, LLC. (“CorneaGen Japan”) (CorneaGen US and CorneaGen Japan referred to collectively as “CorneaGen”) and S-RACMO CO., LTD. (“SR”), a joint venture between Sumitomo Chemical Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. (“SUMITOMO”), with offices at 33-94 Enoki-Cho, Suita, Osaka, Japan. CorneaGen and SR are each individually a “Party” and collectively the “Parties.”
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF...Master Development and Manufacturing Services Agreement • December 10th, 2024 • Aurion Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledDecember 10th, 2024 Company IndustryTHIS MASTER DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT is made as of April 1, 2021 (the “Effective Date”) by and among CORNEAGEN INC. (“CorneaGen US”), a Delaware corporation, having an address at [Omitted] and its wholly owned subsidiary, CorneaGen Japan, LLC. (“CorneaGen Japan”) (CorneaGen US and CorneaGen Japan referred to collectively as “CorneaGen”) and S-RACMO CO., LTD. (“SR”), a joint venture between Sumitomo Chemical Co., Ltd. and Sumitomo Dainippon Pharma Co., Ltd. (“SUMITOMO”), with offices at 33-94 Enoki-Cho, Suita, Osaka, Japan. CorneaGen and SR are each individually a “Party” and collectively the “Parties.”